Cancer imaging with therapy: theranostics
A cancer and imaging technology, applied in preparations for in vivo experiments, medical preparations containing active ingredients, scientific instruments, etc., can solve the problems of undiscussed imaging and treatment combination methods, and achieve the effect of reducing side effects and less procedures
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0096] Example 1. Tumor-specific imaging by gene expression driven by the progression-escalating gene-3 promoter
[0097] feed
[0098] Molecular genetic imaging is progressing from a valuable preclinical tool to guiding patient management. This strategy involves the pairing of imaging reporters with complementary imaging reagents in a system that can be used to measure gene expression, protein interactions, or track genetically marked cells in vivo. Tissue-specific promoters can be used to map gene expression in specific tissues, especially when combined with appropriate amplification mechanisms. Here we show that the progression-promoting gene-3 promoter (PEG-PROM), derived from a rodent gene that regulates the malignant phenotype, can be used to selectively drive a reporter for imaging, enabling Radionuclide-Based Molecular Imaging Techniques to Detect Micrometastatic Disease in Murine Models of Human Melanoma and Breast Cancer. Because of the robust promoter, tumor spec...
Embodiment 2
[0164] summary:
[0165] Cancer target images retain meaningful but forgettable targets. Such images can provide early diagnosis, aid in treatment planning, and are profoundly beneficial in treatment monitoring. We cross by subtraction 3 Identification of the minimal promoter region of the rodent PEG-3 gene-derived progression promotion gene-3 (PEG-Prom) 1,2 , expression of the rodent PEG-3 gene is directly associated with malignant transformation and tumor progression in rodent tumors, as well as in human tumors 3,4 , said human tumors include brain, prostate, breast, melanoma, and pancreatic 5-9 Tumor-derived cancer cell lines in . Based on these findings, we hypothesized, and subsequently demonstrated, that the systemic delivery of PEG-Prom associated with and regulated by the image construct would enable broadly applicable tumors or subtypes of different tissue origins. 10 This results in tumor-specific expression of the reporter gene not only within the primary tumor...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com